Literature DB >> 1582820

Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.

S L Hanna1, D M Parham, D L Fairclough, W H Meyer, A H Le, B D Fletcher.   

Abstract

RATIONALE AND
OBJECTIVES: To improve the accuracy of magnetic resonance imaging (MRI) in evaluating the response of osteosarcomas to preoperative chemotherapy, the authors developed a technique of mapping tumor necrosis and viability by quantitating slope values of gadolinium-DTPA (Gd-DTPA) uptake on dynamic fast low-angle shot (FLASH) images.
METHODS: Dynamic contrast-enhanced FLASH imaging of a single representative plane was performed on six osteosarcomas. Tumors were mapped by dividing resultant images into contiguous regions of interest and deriving slopes representing percentage increase in signal intensity (SI) per minute over the baseline for each region. The results were compared with estimations of viable tumor volume on subtracted Gd-DTPA-enhanced T1-weighted images and histologic maps of necrotic and viable tumor.
RESULTS: Dynamic FLASH estimations of percent tumor necrosis using a critical slope value of 45% per minute correctly predicted histologic response to chemotherapy in all six patients. Comparison of dynamic FLASH and histologic maps showed a high degree of correlation. Static enhanced T1-weighted images overestimated the amount of residual viable tumor.
CONCLUSIONS: Dynamic FLASH Gd-DTPA-enhanced mapping is a potentially useful noninvasive method of quantitating tumor response to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582820     DOI: 10.1097/00004424-199205000-00010

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.

Authors:  Yoshiko Hayashida; Toshitake Yakushiji; Kazuo Awai; Kazuhiro Katahira; Yoshiharu Nakayama; Osamu Shimomura; Mika Kitajima; Toshinori Hirai; Yasuyuki Yamashita; Hiroshi Mizuta
Journal:  Eur Radiol       Date:  2006-08-15       Impact factor: 5.315

2.  Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.

Authors:  Seong-Hwan Moon; Kyoo-Ho Shin; Jin-Suck Suh; Woo-Ick Yang; Jae-Keong Noh; Soo-Bong Hahn
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

3.  Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results.

Authors:  Catherina S P van Rijswijk; Maartje J A Geirnaerdt; Pancras C W Hogendoorn; Johannes L Peterse; Frits van Coevorden; Antonie H M Taminiau; Rob A E M Tollenaar; Bin B R Kroon; Johan L Bloem
Journal:  Eur Radiol       Date:  2003-01-08       Impact factor: 5.315

4.  Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging.

Authors:  H J van der Woude; J L Bloem; H C Holscher; M A Nooy; A H Taminiau; J Hermans; T H Falke; P C Hogendoorn
Journal:  Skeletal Radiol       Date:  1994-10       Impact factor: 2.199

5.  New approach for assessing vascular distribution within bone tumors using dynamic contrast-enhanced MRI.

Authors:  Yukio Kawakami; Toshiyuki Kunisada; Shinsuke Sugihara; Atsushi Ono; Keiichiro Nishida; Nobuhiro Abe; Akira Kawai; Kazuo Fujiwara; Yuki Morimoto; Toshifumi Ozaki
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-30       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.